Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03081390 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Migraine and CVD Risk in Women

StatusTerminated
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial terminated Sponsor's reason: Investigator transition Primary completion pushed from Jun 30, 2020 to Sep 28, 2026 · Final enrollment: 23 participants (planned 30) · Study completion date changed from estimate of Jun 30, 2026 to Sep 28, 2026 · 3 more Show 6 more changesShow less
    • Primary completion pushed from Jun 30, 2020 to Sep 28, 2026
    • Final enrollment: 23 participants (planned 30)
    • Study completion date changed from estimate of Jun 30, 2026 to Sep 28, 2026
    • Interventions: Flow-mediated dilation testing (Other), Mixed meal tolerance testing (Other), Skin conductance & cold pressor test (Other) to Flow-mediated dilation testing (Other), Mixed meal tolerance testing (Other), Skin conductance & cold pressor test (Other)
    • Eligibility criteria expanded, about 13 words
    • Site details revised at 1 of 2 sites
  2. Completion date: Jun 30, 2025 to Jun 30, 2026v15
  3. Completion date: Jun 30, 2024 to Jun 30, 2025v14
  4. Completion date: Jun 30, 2023 to Jun 30, 2024v13
  5. Completion date: Jun 30, 2022 to Jun 30, 2023v12
Show 10 earlier versionsHide 10 earlier versions
  1. Completion date: Jun 2021 to Jun 30, 2022v11
  2. Primary completion date changed from estimate of Jun 2020 to Jun 30, 2020 Completion date: Jun 2020 to Jun 2021v10 Show 1 more changeShow less
    • Completion date: Jun 2020 to Jun 2021
  3. Primary completion date: Jun 2019 to Jun 2020 Trial status: Recruiting to Active, Not Recruiting · Site details revised at 2 of 2 sitesv9 Show 2 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 2 of 2 sites
  4. Primary completion date: Mar 2019 to Jun 2019 Completion date: Mar 2020 to Jun 2020v8 Show 1 more changeShow less
    • Completion date: Mar 2020 to Jun 2020
  5. Primary completion date: Sep 2018 to Mar 2019 Completion date: Sep 2018 to Mar 2020v7 Show 1 more changeShow less
    • Completion date: Sep 2018 to Mar 2020
  6. Eligibility criteria revisedv6 See this version in full on ClinicalTrials.gov ↗
  7. Primary and study completion dates: Feb 2018 to Sep 2018v5
  8. Eligibility criteria expanded, about 18 wordsv4 See this version in full on ClinicalTrials.gov ↗
  9. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Mar 2017 to Apr 1, 2017 · Site details revised at 2 of 2 sitesv3 Show 2 more changesShow less
    • Start date changed from estimate of Mar 2017 to Apr 1, 2017
    • Site details revised at 2 of 2 sites
  10. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary goal of this study is to test the effects of a high-fat, high-carbohydrate mixed meal on candidate modulators of cardiovascular disease risk (inflammation, vascular reactivity, sympathetic nervous system tone, and response to pain) in young adult women with migraine compared with healthy young women. This is study enrolling both cases (women with migraine) and controls (women without migraine), with equal numbers of normal weight and obese women in each group. Participants will undergo a telephone screening and a single day in-person study visit.
Trial Details
NCT Number NCT03081390
Lead Sponsor University of Pennsylvania
Conditions Migraine
Enrollment 23 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov